Equipment Leasing Small Business News + More Drugmakers Point Finger at Middlemen for Rising Drug Prices + MORE 10/02/2016

Tesla Motors posted its best sales quarter ever ahead of efforts to raise additional cash that it will need to begin production of the Model 3 sedan.

In the global struggle to boost growth, a Canadian experiment in fiscal spending is providing a test case for some of the world’s biggest economies.

Whatever your hustle is, I salute you.

WhiteWave Foods shareholders this week are expected to support a $10.4 billion takeover bid by French dairy giant Danone, despite concerns among some investors and organic industry groups about the deal.

Live your life — your way.

As U.S. drug prices rise, drugmakers are playing down their role, instead heaping blame on the middlemen who help determine how medicines are priced.

For campaigns striving to get supporters to the polls, as well as change minds, the ability to “micro-target” is manna from heaven, writes Christopher Mims.

As some of the world’s biggest oil companies pull back from Asia, they’re paving the way for local rivals to take a bigger role.

Danish pharmaceutical company Novo Nordisk is moving into the complex and more expensive business of inventing new forms of insulin, which would bring it closer to the riskier drug-discovery activities of the wider pharmaceutical industry.

Sometimes — no, oftentimes — two heads are better than one.

ASML, a little-known company based in the Netherlands, may hold the answer to a question hanging over the global semiconductor industry: how to make chips do more while keeping them the same, compact size.

American Airlines Group Inc., which over the weekend surmounted a major information-technology challenge, said Sunday it was “really pleased” with the transition.

The yuan officially enters the International Monetary Fund’s official basket of reserve currencies Saturday, a trophy for China in the transformation of the communist nation’s geopolitical status.

Kelsey Humphreys sits down with entrepreneur Matt Britton to discuss how he built a multimillion dollar award-winning agency.